Loading insider details...
Latest Form 4 (Nov 6, 2026): Sale of 2,826 ANTX shares, $11.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | AN2 Therapeutics, Inc. (ANTX) | Sale | 2,826 | $11.9K |
| Jul 10, 2026 | AN2 Therapeutics, Inc. (ANTX) | Sale | 5,945 | $24.8K |
| Mar 23, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 92,000 | n/a |
| Feb 23, 2026 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 50,000 | n/a |
| Jan 8, 2026 | AN2 Therapeutics, Inc. (ANTX) | Sale | 17,923 | $17.9K |
| Nov 6, 2025 | AN2 Therapeutics, Inc. (ANTX) | Sale | 2,819 | $3.2K |
| Feb 28, 2025 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 58,500 | n/a |
| Jan 8, 2025 | AN2 Therapeutics, Inc. (ANTX) | Sale | 9,663 | $13.0K |
| Nov 5, 2024 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 31,500 | n/a |
| Jul 12, 2024 | AN2 Therapeutics, Inc. (ANTX) | Grant/Award | 60,000 | n/a |